Cite
Evaluation of KIF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinoma.
MLA
Xiaotong Sun, et al. “Evaluation of KIF23 Variant 1 Expression and Relevance as a Novel Prognostic Factor in Patients with Hepatocellular Carcinoma.” BMC Cancer, vol. 15, Dec. 2015, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s12885-015-1987-1.
APA
Xiaotong Sun, Zhongtian Jin, Xiao Song, Jingjing Wang, Yan Li, Xiaoping Qian, Yu zhang, Yanhui Yin, Sun, X., Jin, Z., Song, X., Wang, J., Li, Y., Qian, X., zhang, Y., & Yin, Y. (2015). Evaluation of KIF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinoma. BMC Cancer, 15, 1–9. https://doi.org/10.1186/s12885-015-1987-1
Chicago
Xiaotong Sun, Zhongtian Jin, Xiao Song, Jingjing Wang, Yan Li, Xiaoping Qian, Yu zhang, et al. 2015. “Evaluation of KIF23 Variant 1 Expression and Relevance as a Novel Prognostic Factor in Patients with Hepatocellular Carcinoma.” BMC Cancer 15 (December): 1–9. doi:10.1186/s12885-015-1987-1.